FinTrust Capital Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1,432
Closed -$10K – 1197
2022
Q3
$10K Sell
1,432
-356
-20% -$2.79K ﹤0.01% 862
2022
Q2
$14K Buy
1,788
+308
+21% +$3.14K ﹤0.01% 792
2022
Q1
$21K Buy
1,480
+442
+43% +$5.92K ﹤0.01% 750
2021
Q4
$15K Sell
1,038
-572
-36% -$8.13K ﹤0.01% 817
2021
Q3
$23K Buy
+1,610
New +$24.8K 0.01% 701

Other funds holding BVS

FinTrust Capital Advisors's BVS Position: Q4 2022 in Review

FinTrust Capital Advisors sold out of Bioventus (BVS) in Q4 2022, closing a stake of 1,432 shares — an estimated $10K sold.

FinTrust Capital Advisors first reported a position in BVS in Q3 2021 and held it in 5 quarters. The position peaked at $23K in Q3 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • FinTrust Capital Advisors reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 1,432 Bioventus shares in Q4 2022, an estimated $10K.
  • FinTrust Capital Advisors first reported a position in Bioventus in Q3 2021 and held it in 5 quarters.
  • FinTrust Capital Advisors's Bioventus position peaked at $23K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on FinTrust Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.